ampatill

Buying opportunity in Stride pharma

Long
NSE:STAR   STRIDES PHARMA SCI
On weekly charts, this scripts seems on strong support zone near 280 indicating the ascending RSI above 30 levels.
On financial sides, though the YoY revenue generation is seen weak, the Q4 revenue is up by more than 6.50%.
Short term holding can deliver targets 320, 342, 360
Disclaimer

The information and publications are not meant to be, and do not constitute, financial, investment, trading, or other types of advice or recommendations supplied or endorsed by TradingView. Read more in the Terms of Use.